Interestingly, genes which are targets of YAP are decreased in TZD-treated cells with a concurrent decrease in the nuclear localization of Sox2 and YAP, suggesting that TZD treatment in osteosarcomas restores the effect of tumor suppressive Hippo signaling. The gene discussed is YAP1; the disease is neoplasm.